Skip to main content
HOW IT WORKS
“Learning more about B-cell treatments and how KESIMPTA® was precisely delivered made me feel more comfortable getting started.” —WALT D, Chose KESIMPTA as 1st treatment: 2021

How KESIMPTA Works

KESIMPTA is the only B-cell treatment for RMS that’s delivered as a once-monthly* at-home injection.

*Once monthly after 3 weekly starter doses.

WHAT HAPPENS IN RMS

To understand how KESIMPTA works, it’s important to know how B-cells and relapsing MS are connected.

Illustration depicting B-cells distributed throughout the body and RMS-related B-cells located in the lymph nodes

For illustrative purposes only.

B-Cell Icon

B-Cells

B-cells are a part of the immune system that help fight infections. They are found throughout the body.

RMS-related B-cell Icon

RMS-related B-cells

In RMS, immune cells, such as B-cells, located in the lymph nodes, are mistakenly sent to attack the body's myelin—the protective covering around the nerves in the brain and spinal cord.

KESIMPTA IS PRECISELY DELIVERED

While it’s not fully understood how KESIMPTA works, it’s designed to target the B-cells in the lymph nodes believed to play a role in RMS.

Think of your body as a maze with many possible paths:

Illustration depicting a maze with regular B-cell icons scattered throughout and RMS-related B-cell icons located only in the center. A KESIMPTA auto-injector pen is shown using a precise path to the center of the maze. Because of this direct path, the pen can get to the RMS-related B-cell icons without interfering with regular B-cell icons on the way.

For illustrative purposes only.

RMS-related B-cell Icon

RMS-related B-cells

As a subcutaneous injection just under the skin, KESIMPTA is thought to target a precise path to RMS-related B-cells.

B-Cell Icon

B-Cells

Based on preclinical studies.

Targeted delivery with the KESIMPTA Sensoready® Pen to the lymph nodes is thought to limit the impact on other B-cells your body needs to maintain immune function.

Sean Image

SEAN C.
Dad, Science Teacher
Switched to KESIMPTA: 2020

As a biochemist, I was excited about the only at-home, B-cell RMS therapy with subcutaneous delivery.

Watch how to use the pen step-by-step

The details are here for you

Sign Up Icon

Want more information to help you decide?

Find out why so many people are choosing KESIMPTA.

Phone Headset Icon

Want co-pay help?

97% of all prescriptions filled have a $0 out of pocket cost when used with the Access Card‡§ from the Alongside™ KESIMPTA Patient Support Program.

All people shown on this webpage are living with relapsing multiple sclerosis, have taken KESIMPTA, and have been compensated for their time.
RMS, relapsing multiple sclerosis. 
Limitations apply. Offer not valid under Medicare, Medicaid, or any other federal or state health insurance program. Patients with commercial insurance who are initially denied coverage may receive free KESIMPTA for up to 12 months while seeking coverage. Patients with commercial insurance who have coverage for KESIMPTA may receive up to $18,000 in annual co-pay benefits. Novartis reserves the right to rescind, revoke, or amend this program without notice. Additional limitations may apply. See complete Terms & Conditions at start.kesimpta.com.
§2023 data on file.

KESIMPTA, the KESIMPTA logo, and SENSOREADY are registered trademarks of Novartis AG.
ALONGSIDE and the ALONGSIDE logo are trademarks of Novartis AG. 
AUBAGIO is a registered trademark of Genzyme, a Sanofi company. 
Please see each product’s respective PI for additional information including indication, dosing, and safety.